UBS Group’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,600
Closed -$172K 8064
2019
Q1
$172K Buy
+3,600
New +$218K ﹤0.01% 4710
2017
Q4
Sell
-40,000
Closed -$2.46M 8012
2017
Q3
$2.46M Sell
40,000
-40,000
-50% -$2.46M ﹤0.01% 2942
2017
Q2
$5.03M Hold
80,000
﹤0.01% 2146
2017
Q1
$4.44M Buy
80,000
+40,000
+100% +$2.06M ﹤0.01% 2184
2016
Q4
$1.91M Hold
40,000
﹤0.01% 2951
2016
Q3
$2.59M Buy
+40,000
New +$2.25M ﹤0.01% 2612
2016
Q1
Sell
-200
Closed -$8K 7999
2015
Q4
$8K Hold
200
﹤0.01% 7432
2015
Q3
$8K Hold
200
﹤0.01% 7411
2015
Q2
$9K Sell
200
-200,000
-100% -$10.8M ﹤0.01% 7541
2015
Q1
$12.1M Buy
200,200
+145,000
+263% +$7.38M 0.01% 1326
2014
Q4
$2.41M Buy
+55,200
New +$2.44M ﹤0.01% 2718

Other funds holding NUS

UBS Group's NUS Position: Q1 2026 in Review

UBS Group reduced its Nu Skin (NUS) stake by 32% in Q1 2026, selling an estimated $1.03M and leaving 236,025 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #5103.

UBS Group first reported a position in NUS in Q4 2014 and has held it in 46 quarters since. The position peaked at $19M in Q4 2021. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • UBS Group held 236,025 shares of Nu Skin worth $1.72M as of Q1 2026.
  • UBS Group sold 113,427 Nu Skin shares in Q1 2026, an estimated $1.03M.
  • Nu Skin made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5103 holding.
  • UBS Group first reported a position in Nu Skin in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Nu Skin position peaked at $19M in Q4 2021.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.